Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
385.00    1.00 (0.26%)
Bid:
386.50
Ask:
387.00
Spread: 0.50 (0.129%)
Market Cap: £1.74b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Kepler Trust Intelligence: New Research

23 Oct 2025 07:00

RNS Number : 4404E
HgCapital Trust PLC
23 October 2025
 

HgCapital Trust: New Research

23/10/2025

HGT offers a unique tech exposure that has delivered strong long-term NAV growth…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPGRAUUPAGWP
Date   Source Headline
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.